| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer. | J Clin Oncol | 2006 | 1.92 |
| 2 | Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole. | Cancer | 2011 | 1.36 |
| 3 | Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer. | Clin Colorectal Cancer | 2011 | 1.07 |
| 4 | Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma. | Cancer | 2004 | 0.79 |